Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:      
Net income $ 4,830,771 $ 4,061,643 $ 2,761,896
Adjustments to reconcile net income to net cash provided by operating activities:      
Impairment of goodwill and purchased intangible assets 0 239,100 289,474
Depreciation and amortization 393,978 394,088 401,730
Unrealized foreign exchange (gain) loss and other 6,725 14,974 (12,533)
Asset impairment charges 0 0 11,307
Stock-based compensation expense 310,171 265,011 212,695
Net gain on sale of assets (683) (161) 0
Deferred income taxes 77,795 (246,577) (155,228)
Settlement of treasury lock agreement 0 0 415
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:      
Accounts receivable (641,824) (367,897) (80,894)
Inventories (465,963) (155,170) (164,092)
Other assets (501,420) (10,459) (289,509)
Accounts payable 172,357 33,789 24,976
Deferred system revenue 116,071 (169,027) 334,136
Deferred service revenue (54,617) 100,460 203,106
Other liabilities (100,282) (77,871) (228,904)
Net cash provided by operating activities 4,143,079 4,081,903 3,308,575
Cash flows from investing activities:      
Payments to Acquire Businesses, Net of Cash Acquired 0 0 (3,682)
Capital expenditures (375,945) (335,259) (277,384)
Proceeds from capital-related government assistance 16,782 6,263 0
Purchases of available-for-sale and equity securities (3,711,093) (2,772,578) (2,756,987)
Proceeds from maturity and sale of available-for-sale securities 2,894,046 2,915,435 1,567,637
Purchases of trading securities (264,960) (118,288) (134,098)
Proceeds from sale of trading securities 248,624 105,751 121,020
Other, net 2,451 (3,805) 6,509
Net cash used in investing activities (1,190,095) (202,481) (1,476,985)
Cash flows from financing activities:      
Proceeds from issuance of debt, net of issuance costs (1,602) 0 735,043
Repayment of debt 0 (750,000) 0
Common stock repurchases (2,289,769) (2,149,946) (1,735,746)
Payment of dividends to stockholders (1,057,832) (904,594) (773,041)
Issuance of common stock 168,573 151,514 144,934
Tax withholding payments related to vested and released restricted stock units (204,976) (132,661) (143,024)
Contingent consideration payable and other, net 0 0 (4,183)
Net cash used in financing activities (3,385,606) (3,785,687) (1,776,017)
Effect of exchange rate changes on cash and cash equivalents 3,556 8,044 (6,309)
Net increase (decrease) in cash and cash equivalents (429,066) 101,779 49,264
Cash and cash equivalents at beginning of period 2,078,908 1,977,129 1,927,865
Cash and cash equivalents at end of period 1,649,842 2,078,908 1,977,129
Supplemental cash flow disclosures:      
Income taxes paid, net 781,409 886,937 830,835
Interest paid, net of capitalized interest 282,505 292,771 276,597
Non-cash activities:      
Contingent consideration payable - financing activities 0 0 (765)
Dividends payable - financing activities 8,942 8,660 8,043
Unsettled common stock repurchase - financing activities 5,494 5,500 5,500
Accrued purchases of land, property and equipment - investing activities $ 21,531 $ 25,740 $ 13,849